6:50 PM
 | 
Jan 18, 2007
 |  BC Extra  |  Financial News

Novartis reports earnings

Novartis (NVS; SWX:NOVN) reported fourth quarter earnings per ADS of $0.70, up from $0.58 in the same period last year. Fourth quarter sales rose 12% to $10 billion, including a 12% gain in pharmaceuticals to $6 billion. Sales of Gleevec ( Glivec) imatinib to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST)...

Read the full 261 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >